Acknowledged expertise in Pharmaceuticals & Healthcare matters

In the recent years, the pharmaceuticals and healthcare companies face increasing competition and tighter regulation. MPR Partners’ broad experience and technical understanding of the national and regional pharmaceuticals, medical devices and healthcare services markets enable us to render focused, integrated and cost-effective solutions to our clients.

Lawyers handling our Pharmaceuticals & Healthcare practice have acquired massive expertise in advising a large number of pharmaceutical and biotechnology companies and medical devices manufacturers, including 9 of the largest companies worldwide, as well as healthcare services providers, regulators and professional associations with regard to a plethora of matters spanning from regulatory, cross-border mergers, acquisitions and reorganizations, intellectual property rights, advertising, taxation, employment, litigation and arbitration, insolvency, competition, interactions with government officials and doctors, sponsorships, pricing, clinical and non-interventional trials.

Highlights of the assignments which have been handled by our lawyers throughout their practice include advice and representation to:

• A reputed association of pharmaceuticals companies and medical devices manufacturers, with regard to various regulatory and dispute resolution matters;
• A large international pharmaceuticals company and medical devices manufacturer, in relation to cross-border acquisition and reorganization matters, including commercial, regulatory and compliance, competition, labor and insolvency matters;
• The Romanian affiliate of a large US based pharmaceutical company, in relation to regulatory, dispute resolution, labor, intellectual property and pricing matters;
• A leading Swiss based pharmaceutical company, in relation to regulatory, competition, intellectual property matters, as well on protocols with regulators and government officials;
• The Romanian affiliates of a leading French pharmaceutical company, in connection with regulatory and labor matters;
• A large Japanese pharmaceutical company, in relation to regulatory, compliance, wholesale distribution and promotion matters;
• A large UK based pharmaceutical company, in relation to the spin-off of its pharmacy network and company reorganization;
• A large Danish pharmaceutical company, in connection with regulatory and compliance, as well as intellectual property rights and their enforcement under the Romanian jurisdiction;
• Two large German pharmaceutical companies, with regard to regulatory and compliance matters, including intellectual property related matters;
• Several public and private healthcare services providers in relation to day to day legal matters such as regulatory and compliance, corporate, commercial, labor, financing and reorganization matters;
• An international healthcare services provider, in connection with mergers & acquisitions, reorganization, labor, dispute resolution, compliance, competition, intellectual property and taxation matters.

Publications

• Changes to the Romanian pharmacy law, November 2020 (ENG)
• Life Sciences: product regulation and liability in Romania, Lexology Navigator, May 2018 (ENG)
• Healthcare and Life Sciences in Romania (ENG)

• back